Jiawen Xie, Hayam Hamdy, Eyad Elkord. Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities. // Trends in Pharmacological Sciences. – 2026. – DOI: 10.1016/j.tips.2026.03.007. – URL: https://doi.org/10.1016/j.tips.2026.03.007
Jiawen Xie, Hayam Hamdy, & Eyad Elkord (2026). Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2026.03.007
Jiawen Xie, et al. “Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities.” Trends in Pharmacological Sciences, 2026. doi:10.1016/j.tips.2026.03.007.
@article{Xie2026,
title = {Treg-directed cancer immunotherapy beyond immune checkpoints: progress and opportunities},
author = {Xie, Jiawen and Hamdy, Hayam and Elkord, Eyad},
journal = {Trends in Pharmacological Sciences},
year = {2026},
doi = {10.1016/j.tips.2026.03.007},
url = {https://doi.org/10.1016/j.tips.2026.03.007}
}